Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 4,156,728 |
|
|||||
| News | - | ||||||
| Day High | 12.90 | Low High |
|||||
| Day Low | 12.31 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.37 | 2.96% | 12.87 | 18:23:21 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.87 | 12.31 | 12.90 | 12.88 | 12.50 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 31,508 | 4,156,728 | US$ 12.64 | US$ 52,525,990 | - | 3.21 - 18.33 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:56:02 | 15 | US$ 12.88 | USD |
Iovance Biotherapeutics (IOVA) Options Flow Summary
Iovance Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.6B | 279.31M | - | 1.19M | -444.04M | -1.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Iovance Biotherapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.50 | 12.9974 | 11.16 | 11.98 | 4,125,992 | 1.37 | 11.91% |
| 1 Month | 14.08 | 14.21 | 11.01 | 12.25 | 4,199,800 | -1.21 | -8.59% |
| 3 Months | 8.08 | 18.33 | 7.96 | 14.06 | 9,204,694 | 4.79 | 59.28% |
| 6 Months | 3.92 | 18.33 | 3.76 | 10.65 | 8,330,605 | 8.95 | 228.32% |
| 1 Year | 6.37 | 18.33 | 3.21 | 8.87 | 7,184,830 | 6.50 | 102.04% |
| 3 Years | 31.88 | 32.10 | 3.21 | 10.63 | 4,473,086 | -19.01 | -59.63% |
| 5 Years | 11.16 | 54.2081 | 3.21 | 14.32 | 3,324,006 | 1.71 | 15.32% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma. |
